GEM Funds: Positioning Chart Pack, Jan 2025

348 emerging market Funds, AUM $418bn Active GEM Funds: Positioning Chart Pack, Jan 25 Headlines In this chart pack, we highlight 10 key investment themes across our Global Emerging Market fund universe. 1. Active Shares Hit All-Time Lows2. The Small Cap Effect3. Have we Seen Peak ESG?4. The Big Rotations in 2024.5. GCC a Key Focus for EM Investors in …

Continue Reading

China Funds: Performance & Attribution, 2024

138 active China equity funds, AUM $38bn China Funds: Performance & Attribution, 2024 Summary Active China managers suffered another extremely challenging year when compared to the iShares MSCI China benchmark.  Average returns came in at 9.78%, falling short of the iShares MCHI ETF by 7.39%. Only 10.5% of funds managed to outperform the benchmark. Returns were spread between a high …

Continue Reading

UK Funds: Performance & Attribution, 2024

241 active UK equity funds, AUM $169bn UK Funds: Performance & Attribution, 2024 Summary Active UK funds achieved an average return of +8.21% in 2024, trailing the SPDR FTSE All Share ETF by -0.82% and with 40.4% of funds outperforming the benchmark during the year. Individual fund performance showed fairly large dispersion, ranging from a peak of +24.5% to a …

Continue Reading

Asia Ex-Japan: Performance & Attribution, 2024

98 Asia Ex-Japan active equity funds, AUM $55bn Asia Ex-Japan Funds: Performance & Attribution, 2024 Summary Active Asia Ex-Japan managers had a challenging 2024, underperforming the iShares AAXJ ETF by -1.74% after posting returns of 8.68% on average. The return picture was skewed by a number of heavily underperforming funds from the Growth bucket, and actually, 43% of funds outperformed …

Continue Reading

GEM Funds: Performance & Attribution, 2024

348 emerging market Funds, AUM $418bn Active GEM Funds: Performance & Attribution, 2024 Headlines GEM Funds Aligned with Benchmark in 2024 Active EM Funds posted an average return of +6.08% in 2024, trailing the iShares MSCI Emerging Markets ETF by 0.46%. Just under half (47.5%) of funds managed to outperform the index. 2024 returns ranged from -13.6% to +28.3%, with …

Continue Reading

Global Funds: Performance & Attribution Review, 2024

336 Global active equity funds, AUM $1.2tr Global Funds: Performance & Attribution, 2024   Summary Record Underperformance. 2024 proved to be a challenging year for active Global equity funds, with average returns of 11.97% falling -5.08% short of the SPDR MSCI ACWI ETF, and only 23.6% of funds managing to beat the index. It was the worst year in terms …

Continue Reading

Asia Ex-Japan Funds: Positioning Insights, December 2024

98 Asia Ex-Japan active equity funds, AUM $55bn Asia Ex-Japan Funds: Positioning Insights, Dec 24 Summary Top-Down Positioning Update China dominates allocations, India and Taiwan are equal 2nd, while South Korea lags a further 7% behind. Indonesia leads the ASEAN region, emerging as the top overweight country as a record 79.8% of funds are ahead of the benchmark. In contrast, …

Continue Reading

EM Positioning Insights, December 2024

348 emerging market Funds, AUM $418bn Active GEM Funds: Positioning Insights, December 2024 Headlines South Korea:Rotation Drives Exposure to Record Lows Real Estate:Recovery Among Active EM Funds South Africa Financials:Gaining Momentum Among EM Investors Chart Pack South Korea Chart Pack Real Estate Chart Pack S. Africa Financials For more analysis, data or information on active investor positioning in your market, …

Continue Reading

Global Funds: Positioning Insights, December 2024

336 Global active equity funds, AUM $1.2tr Global Funds: Positioning Insights, December 2024 Summary United KingdomOverweight Positioning Hits Fresh Highs Motor VehiclesFall in Investor Confidence Nestle’s Fall From Grace Global Funds Pull Back Data Pack Links United Kingdom Health Care For more analysis, data or information on active investor positioning in your market, please get in touch with me on …

Continue Reading

Active Global Funds: Positioning Chart Pack, November 2024

336 Global active equity funds, AUM $1.1tr Active Global Funds: Positioning Chart Pack Summary In this chart pack, we highlight the key country, sector and stock exposures among active Global equity funds. The end of the report includes profiles of the key countries and sectors, providing further details on stock and fund-level exposures. Country Analysis: The USA remains the cornerstone …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley